Cargando…

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs

Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, Weverson A., Islam, Arshad, Andrade, Aretha Priscilla S., Fernandes, Flaviana R., Frézard, Frédéric, Demicheli, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270655/ https://www.ncbi.nlm.nih.gov/pubmed/24786687 http://dx.doi.org/10.3390/molecules19055478

Ejemplares similares

Pentavalent Antimonials: New Perspectives for Old Drugs
por: Frézard, Frédéric, et al.
Publicado: (2009)

The Pentavalent Antimony Compounds in Tropical Medicine
por: Schmidt, Hans
Publicado: (1928)

New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
por: Shin, Ji Yeon, et al.
Publicado: (2013)

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017)

Improved Antileishmanial Activity of Dppz through Complexation with Antimony(III) and Bismuth(III): Investigation of the Role of the Metal
por: Lizarazo-Jaimes, Edgar H., et al.
Publicado: (2012)

Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony()
por: Moreira, Douglas S., et al.
Publicado: (2013)

Cytotoxicity and In Vitro Antileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol
por: Rocha, Marcele Neves, et al.
Publicado: (2013)

In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate
por: Carrió, Jaume, et al.
Publicado: (2002)

Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
por: Oliveira, Rodrigo A, et al.
Publicado: (2012)

Reactions Following the Administration of the Pentavalent Compounds of Antimony: An Analysis of Cases Reported by Several Correspondents
por: Napier, L. Everard
Publicado: (1926)

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline
por: Cincura, Carolina, et al.
Publicado: (2022)

Antimony(V) and Bismuth(V) Complexes of Lapachol: Synthesis, Crystal Structure and Cytotoxic Activity
por: de Oliveira, Ludmila G., et al.
Publicado: (2011)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
por: Rodrigues, Bruna Côrtes, et al.
Publicado: (2020)

On the Detection of Antimony in Mixed Fluids
por: Turner, Edward
Publicado: (1827)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
por: Martins, Sofia Sales, et al.
Publicado: (2021)

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review
por: Berbert, Taisa Rocha Navasconi, et al.
Publicado: (2018)

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
por: Marques, Sílvio Alencar, et al.
Publicado: (2019)

Gene Expression Profiling and Molecular Characterization of Antimony Resistance in Leishmania amazonensis
por: do Monte-Neto, Rubens L., et al.
Publicado: (2011)

Antimony Toxicity
por: Sundar, Shyam, et al.
Publicado: (2010)

Antimony and Filariasis
por: Rao, P. Rajeswara
Publicado: (1926)

An Antimony Rash
por: Kundu, Sarat Sasi
Publicado: (1925)

On Antimoniated Ointment
Publicado: (1826)

Poisoning by Antimony
Publicado: (1903)

The Therapeutics of Antimony
por: Chopra, R. N., et al.
Publicado: (1923)

Antimony in Malaria
Publicado: (1944)

The Use of Antimony
Publicado: (1890)

Etymologia: Antimony
por: Walker, Mark D.
Publicado: (2018)

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
por: Miranda-Verastegui, Cesar, et al.
Publicado: (2009)

Potent heme-degrading action of antimony and antimony-containing parasiticidal agents
por: Drummond, GS, et al.
Publicado: (1981)

Identification of Antimony- and Arsenic-Oxidizing Bacteria Associated with Antimony Mine Tailing
por: Hamamura, Natsuko, et al.
Publicado: (2013)

Oligosilanylated Antimony Compounds
por: Zitz, Rainer, et al.
Publicado: (2015)

Leishmania Sores and Antimony
por: Narasimhan, N. S.
Publicado: (1918)

Advances in the Therapeutics of Antimony
Publicado: (1938)

Some Uses of Antimony
Publicado: (1892)

Use of Antimony in Ophthalmia
por: Fielding, George
Publicado: (1813)

On Muriat and Tartrit of Antimony
por: Stott, Robert
Publicado: (1805)

Gold Containing Antimony
Publicado: (1860)

Inoculation with Tartarized Antimony
Publicado: (1846)

Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate
por: Coelho, Deise Riba, et al.
Publicado: (2014)

Urinary Excretion of Antimony after Administration of Methyl Glucamine Antimoniate. Preliminary Observations
por: Chakravarti, R. N., et al.
Publicado: (1950)

Cannot write session to /tmp/vufind_sessions/sess_dcfqnjknhdv6ospsh6dtco26bh